Haibo Yu
Key Laboratory Of Molecular Biology For Infectious Diseases
Chongqing, China
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation.
Journal: Cancer communications (London, England)
Published: November 04, 2025
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
Journal: Cancer research
Published: October 09, 2025
Rapavir, a novel inhibitor of sodium taurocholate cotransporting polypeptide, potently blocks hepatitis B virus entry.
Journal: Signal transduction and targeted therapy
Published: February 27, 2025
Emerging Serum Biomarkers for Chronic Hepatitis B: Focus on Serum HBV RNA and HBcrAg.
Journal: Journal of clinical and translational hepatology
Published: February 11, 2025
Correction: ZNF148 inhibits HBV replication by downregulating RXRα transcription.
Journal: Virology journal
Published: June 25, 2024
Asiatic acid inhibits HBV cccDNA transcription by promoting HBx degradation.
Journal: Virology journal
Published: June 17, 2024
Neuropilin-1 is a novel host factor modulating the entry of hepatitis B virus.
Journal: Journal of hepatology
Published: April 18, 2024
ZNF148 inhibits HBV replication by downregulating RXRα transcription.
Journal: Virology journal
Published: November 23, 2023
HOXA-AS2 Epigenetically Inhibits HBV Transcription by Recruiting the MTA1-HDAC1/2 Deacetylase Complex to cccDNA Minichromosome.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 18, 2023
Sphondin efficiently blocks HBsAg production and cccDNA transcription through promoting HBx degradation.
Journal: Journal of medical virology
Published: September 04, 2022
Last Updated: 09/26/2026